Terveystalo Oyj
TTALF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,340 | $1,286 | $1,259 | $1,155 |
| % Growth | 4.2% | 2.2% | 9.1% | – |
| Cost of Goods Sold | $550 | $983 | $526 | $489 |
| Gross Profit | $790 | $303 | $733 | $666 |
| % Margin | 59% | 23.6% | 58.2% | 57.7% |
| R&D Expenses | $0 | $12 | $8 | $3 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $11 | $9 | $9 | $7 |
| Sales & Mktg Exp. | $11 | $9 | $9 | $7 |
| Other Operating Expenses | $663 | $297 | $1 | $1 |
| Operating Expenses | $674 | $318 | $667 | $553 |
| Operating Income | $116 | -$15 | $34 | $110 |
| % Margin | 8.7% | -1.1% | 2.7% | 9.5% |
| Other Income/Exp. Net | -$27 | -$24 | -$3 | -$9 |
| Pre-Tax Income | $90 | -$39 | $31 | $101 |
| Tax Expense | $18 | $3 | $7 | $20 |
| Net Income | $72 | -$42 | $24 | $81 |
| % Margin | 5.4% | -3.3% | 1.9% | 7% |
| EPS | 0.57 | -0.33 | 0.19 | 0.63 |
| % Growth | 272.7% | -273.7% | -69.8% | – |
| EPS Diluted | 0.57 | -0.33 | 0.19 | 0.63 |
| Weighted Avg Shares Out | 127 | 127 | 127 | 127 |
| Weighted Avg Shares Out Dil | 127 | 127 | 127 | 128 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $0 | $0 | $0 |
| Interest Expense | $28 | $23 | $10 | $9 |
| Depreciation & Amortization | $102 | $107 | $135 | $92 |
| EBITDA | $217 | $91 | $176 | $202 |
| % Margin | 16.2% | 7% | 13.9% | 17.5% |